Diabetes

How leptin, the 'satiety hormone,' reverses diabetes

(Medical Xpress)—Treatment with leptin, the hormone associated with fullness or satiety, reverses hyperglycemia in animals models of poorly controlled type 1 (T1D) and type 2 (T2D) diabetes by suppressing the neuroendocrine ...

Diabetes

Review compares outcomes, safety for once-weekly GLP-1RAs

(HealthDay)—Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) treatments, according to a review published online Dec. 8 in the Annals of Internal Medicine.

Diabetes

Could acupuncture help ward off diabetes?

It's been used for thousands of years to treat a variety of illnesses—and now acupuncture could also help fight one of the 21st century's biggest health challenges.

Diabetes

Maternal hyperglycemia not linked to obesity in offspring

(HealthDay)—Maternal hyperglycemia seems not to be a risk factor for obesity in offspring aged 5 to 7 years after adjustment for maternal body mass index (BMI), according to a study published online June 19 in Diabetes ...

Diabetes

Delta9-tetrahydrocannabivarin beneficial in type 2 diabetes

(HealthDay)—For patients with non-insulin-treated type 2 diabetes, Δ9-tetrahydrocannabivarin (THCV) reduces fasting plasma glucose, and improves pancreatic β-cell function, adiponectin, and apolipoprotein A, according ...

Diabetes

Pioglitazone cuts diabetes risk after ischemic stroke, TIA

(HealthDay)—For insulin-resistant patients with recent ischemic stroke or transient ischemic attack, pioglitazone is associated with reduced risk of diabetes, according to a study published online July 27 in Diabetes Care.

page 1 from 8